Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating expenses:    
Research and development $ 165,750 $ 364,152
General and administrative 815,106 1,252,444
Total Operating Expenses 980,856 1,616,596
Loss from Operations (980,856) (1,616,596)
Other income (expenses):    
Change in fair value of derivative liabilities (5,702) (80,043)
Interest income (expense), net 2,522 (851)
Other income 2,350 56,909
Total other income (expenses) (830) (23,985)
Net Loss $ (981,686) $ (1,640,581)
Net loss per common share - basic and diluted $ (0.08) $ (0.14)
Weighted average number of common shares outstanding - basic and diluted 12,532,840 12,035,335